431 related articles for article (PubMed ID: 29788226)
1. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness.
Puzantian H; Akers SR; Oldland G; Javaid K; Miller R; Ge Y; Ansari B; Lee J; Suri A; Hasmath Z; Townsend R; Chirinos JA
Am J Hypertens; 2018 Aug; 31(9):988-994. PubMed ID: 29788226
[TBL] [Abstract][Full Text] [Related]
2. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.
Sardana M; Vasim I; Varakantam S; Kewan U; Tariq A; Koppula MR; Syed AA; Beraun M; Drummen NE; Vermeer C; Akers SR; Chirinos JA
Am J Hypertens; 2017 Feb; 30(2):196-201. PubMed ID: 27927630
[TBL] [Abstract][Full Text] [Related]
3. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.
Mayer O; Seidlerová J; Wohlfahrt P; Filipovský J; Vaněk J; Cífková R; Windrichová J; Topolčan O; Knapen MH; Drummen NE; Vermeer C
J Hum Hypertens; 2016 Jul; 30(7):418-23. PubMed ID: 26016598
[TBL] [Abstract][Full Text] [Related]
4. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K Status, Warfarin Use, and Arterial Stiffness in Heart Failure.
Hashmath Z; Lee J; Gaddam S; Ansari B; Oldland G; Javaid K; Mustafa A; Vasim I; Akers S; Chirinos JA
Hypertension; 2019 Feb; 73(2):364-370. PubMed ID: 30580682
[TBL] [Abstract][Full Text] [Related]
6. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
[TBL] [Abstract][Full Text] [Related]
7. Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients.
Fain ME; Kapuku GK; Paulson WD; Williams CF; Raed A; Dong Y; Knapen MHJ; Vermeer C; Pollock NK
Am J Hypertens; 2018 May; 31(6):735-741. PubMed ID: 29635270
[TBL] [Abstract][Full Text] [Related]
8. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies.
Wei FF; Drummen NE; Schutte AE; Thijs L; Jacobs L; Petit T; Yang WY; Smith W; Zhang ZY; Gu YM; Kuznetsova T; Verhamme P; Allegaert K; Schutte R; Lerut E; Evenepoel P; Vermeer C; Staessen JA
EBioMedicine; 2016 Feb; 4():162-9. PubMed ID: 26981580
[TBL] [Abstract][Full Text] [Related]
10. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.
Schurgers LJ; Barreto DV; Barreto FC; Liabeuf S; Renard C; Magdeleyns EJ; Vermeer C; Choukroun G; Massy ZA
Clin J Am Soc Nephrol; 2010 Apr; 5(4):568-75. PubMed ID: 20133489
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
[TBL] [Abstract][Full Text] [Related]
12. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.
Mayer O; Seidlerová J; Bruthans J; Filipovský J; Timoracká K; Vaněk J; Cerná L; Wohlfahrt P; Cífková R; Theuwissen E; Vermeer C
Atherosclerosis; 2014 Jul; 235(1):162-8. PubMed ID: 24835435
[TBL] [Abstract][Full Text] [Related]
13. Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population.
Wei FF; Trenson S; Thijs L; Huang QF; Zhang ZY; Yang WY; Moliterno P; Allegaert K; Boggia J; Janssens S; Verhamme P; Vermeer C; Staessen JA
Nephrol Dial Transplant; 2018 Jul; 33(7):1122-1128. PubMed ID: 28992263
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension.
Chirinos JA; Sardana M; Syed AA; Koppula MR; Varakantam S; Vasim I; Oldland HG; Phan TS; Drummen NEA; Vermeer C; Townsend RR; Akers SR; Wei W; Lakatta EG; Fedorova OV
J Am Soc Hypertens; 2018 Sep; 12(9):681-689. PubMed ID: 30033123
[TBL] [Abstract][Full Text] [Related]
15. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
[TBL] [Abstract][Full Text] [Related]
16. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
[TBL] [Abstract][Full Text] [Related]
17. The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2.
Mayer O; Seidlerová J; Vaněk J; Kielbergerová L; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Trefil L; Knapen MH; Drummen NE; Vermeer C
Maturitas; 2015 Jan; 80(1):82-8. PubMed ID: 25458708
[TBL] [Abstract][Full Text] [Related]
18. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
[TBL] [Abstract][Full Text] [Related]
19. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
[TBL] [Abstract][Full Text] [Related]
20. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
Aoun M; Makki M; Azar H; Matta H; Chelala DN
BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]